Status | Study |
RECRUITING |
Study Name: Applying pGz in Mitochondrial Disease Condition: Mitochondrial Myopathies Date: 2022-07-07 Interventions: Testing with an exercise bicycle that is considered "standard of care" for determination of exercise capacity.Participants will comple |
RECRUITING |
Study Name: Validation of Oxygen Nanosensor in Mitochondrial Myopathy Condition: Mitochondrial Myopathies Date: 2019-09-06 Interventions: The purpose of the study is to test a device called a "nanosensor", which measures oxygen levels (a proxy of mitochondrial function) in m |
Not yet recruiting |
Study Name: Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers Condition: MELAS Syndrome Mitochondrial Respiratory Chain Deficiencies Date: 2017-02-05 Interventions: Drug: KL1333 25 mg oral admini |
Recruiting |
Study Name: The KHENERGY Study Condition: Mitochondrial Diseases Mitochondrial Myopathies Date: 2016-09-13 Interventions: Drug: KH176 Drug: placebo |
Recruiting |
Study Name: Oxidative Capacity and Exercise Tolerance in Ambulatory SMA Condition: Spinal Muscular Atrophy Type 3 Mitochondrial Myopathy Date: 2016-08-31 |
Active, not recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Injections of Elamipretide (MTP-131) in Subjects With Genetically Confirmed Mitochondrial Disease Previously Treated in the Stealth BioTherapeutics SPIMM-201 Study Condition: Primary Mitochondrial Disease Date: 2016-06-13 Interventions: Drug: Elamipretide 40 mg elami |
Recruiting |
Study Name: Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy Condition: Metabolism, Inborn Errors Lipid Metabolism, Inborn Errors Date: 2015-12-09 Interventions: Other: Sugar 10 minutes before exercising, the subjects are given a bolus of glucose solution 0.2 g/kg i |
Recruiting |
Study Name: Fatty Acid Oxidation Defects and Insulin Sensitivity Condition: Very Long-chain Acyl-CoA Dehydrogenase Deficiency Trifunctional Protein Deficiency Date: 2015-07-02 Interventions: Drug: Intralipid/Heparin Co-in |
Recruiting |
Study Name: A Study of Bezafibrate in Mitochondrial Myopathy Condition: Mitochondrial Diseases Date: 2015-03-09 Interventions: Drug: Bezafibrate Bezafibrate 200mg-600mg three times daily for 12 weeks. |
Completed |
Study Name: Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy Condition: Mitochondrial Cytopathies Disorders Date: 2015-03-02 Interventions: Other: high fat diet high fat |